Carter J. King
Corporate Officer/Principal bei PROTAGONIST THERAPEUTICS, INC.
Profil
Carter J.
King's current job is as the Executive Vice President-Business Development at Protagonist Therapeutics, Inc. Mr. King's former jobs include being an Associate Director-Corporate Planning at ALZA Corp.
from 2002 to 2006, a Finance Director at Corixa Corp.
from 1998 to 2002, and a Vice President-Corporate Development at Talphera, Inc. from 2002 to 2015.
Additionally, Mr. King was the VP-Finance & Corporate Development at Omniox, Inc. from 2015 to 2016.
Mr. King's education includes an undergraduate degree from the University of California, Santa Barbara and an MBA from Columbia Business School.
Aktive Positionen von Carter J. King
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Corporate Officer/Principal | 01.09.2018 |
Ehemalige bekannte Positionen von Carter J. King
| Unternehmen | Position | Ende |
|---|---|---|
Omniox, Inc.
 Omniox, Inc. Pharmaceuticals: MajorHealth Technology Omniox, Inc. operates as a biopharmaceutical company which develops medicines for hypoxic diseases. Its technology overcomes fundamental biochemical shortcomings of hemoglobin-based and per fluorocarbon oxygen delivery approaches. The company was founded in 2006 by Stephen P. L. Cary, Michael A. Marletta, Jonathan Winger and Elizabeth Marshall Boon and is headquartered in San Carlos, CA. | Corporate Officer/Principal | 01.01.2016 |
| TALPHERA, INC. | Corporate Officer/Principal | 01.04.2015 |
| ALZA CORPORATION | Corporate Officer/Principal | 01.06.2006 |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Director of Finance/CFO | 01.06.2002 |
Ausbildung von Carter J. King
| University of California, Santa Barbara | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TALPHERA, INC. | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Omniox, Inc.
Omniox, Inc. Pharmaceuticals: MajorHealth Technology Omniox, Inc. operates as a biopharmaceutical company which develops medicines for hypoxic diseases. Its technology overcomes fundamental biochemical shortcomings of hemoglobin-based and per fluorocarbon oxygen delivery approaches. The company was founded in 2006 by Stephen P. L. Cary, Michael A. Marletta, Jonathan Winger and Elizabeth Marshall Boon and is headquartered in San Carlos, CA. | Health Technology |
